glp 1 drugs with fewest side effects GLP-1 medication for diabetes and weight loss Compare GLP-1 Options | Ozempic

The current frontrunners have submitted their products for FDA review, with decisions expected by late 2025

Pterfi Z, Szilvsy-Szab A, Farkas E, et al

Boutari, C

These pharmacokinetic advantages stem directly from orforglipron's non-peptide nature: as a small molecule, it is inherently resistant to proteolytic degradation in the gastrointestinal tract and does not require the pH-dependent, site-specific absorption mechanisms that constrain peptide-based oral formulations (see our peptide research hub)

Ongoing Research The link between GLP-1 and sleep apnea continues to evolve

GLP-1 has quickly become one of the most discussed topics in weight management and metabolic health in the wellness world